Home | Clinical Trials


Therapeutic Areas: Oncology | Gastroenterology | Endocrinology | Family Medicine

Pancreatic Cancer Clinical Trials


A listing of Pancreatic Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Alabama

Birmingham : Alabama Oncology

A Phase 1 clinical study for patients with Tumors, Pancreatic Cancer, Non-small Cell Lung Cancer or Esophagogastric Cancer

Arizona

Scottsdale : Pinnacle Oncology Hematology

A Phase 1 clinical study for patients with Tumors, Pancreatic Cancer, Non-small Cell Lung Cancer or Esophagogastric Cancer

Scottsdale :

Patients are needed to participate in a clinical research study evaluating Ferumoxytol followed by MM-398

Scottsdale : Mayo Clinic Arizona

Patients are needed to participate in a clinical research study to evaluate Metastatic Pancreatic Cancer

Tucson : Arizona Cancer Center

Patients are needed to participate in a clinical research study of FOLFIRINOX, HyperAcute®-Pancreas Immunotherapy, 5-FU Chemoradiation and Gemcitabine to evaluate Pancreatic Cancer, Pancreatic Carcinoma Non-resectable or Locally Advanced Malignant Neoplasm

California

Bakersfield : Comprehensive Blood and Cancer Center

A Phase 1 clinical study for patients with Tumors, Pancreatic Cancer, Non-small Cell Lung Cancer or Esophagogastric Cancer

Burbank : Disney Family Cancer Center

Patients are needed to participate in a clinical research study to evaluate Metastatic Pancreatic Cancer

Duarte : City of Hope National Medical Center

Patients are needed to participate in a clinical research study of FOLFIRINOX, HyperAcute®-Pancreas Immunotherapy, 5-FU Chemoradiation and Gemcitabine to evaluate Pancreatic Cancer, Pancreatic Carcinoma Non-resectable or Locally Advanced Malignant Neoplasm

La Jolla : Scripps Clinic Torrey Pines ( Green Hospital)

Patients are needed to participate in a clinical research study to evaluate Metastatic Pancreatic Cancer

Long Beach : Pacific Shores Medical Group

A clinical trial to evaluate treatments for patients with Pancreatic Cancer

Los Angeles : University of California, Los Angeles

A clinical research study of [124I] PSCA-Minibody PET/CT imaging of the whole body for the treatment of Prostate Cancer, Pancreatic Cancer or Bladder Cancer

Los Angeles : Cedars-Sinai Medical Center

A clinical trial to evaluate treatments using Veliparib, Gemcitabine and Intensity modulated radiation therapy for patients with Pancreatic Cancer

Los Angeles : University of Southern California, Norris Comprehensive Cancer Center

A Phase 1 clinical study for patients with Advanced Solid Tumors

Los Angeles : Cedars-Sinai Medical Center

Patients are needed to participate in a clinical research study of FOLFIRINOX, HyperAcute®-Pancreas Immunotherapy, 5-FU Chemoradiation and Gemcitabine to evaluate Pancreatic Cancer, Pancreatic Carcinoma Non-resectable or Locally Advanced Malignant Neoplasm

San Francisco : California Pacific Medical Center

Patients are needed to participate in a clinical research study of FOLFIRINOX, HyperAcute®-Pancreas Immunotherapy, 5-FU Chemoradiation and Gemcitabine to evaluate Pancreatic Cancer, Pancreatic Carcinoma Non-resectable or Locally Advanced Malignant Neoplasm

San Francisco : University of California-San Francisco Updated

Patients are needed to participate in a clinical research study of OGX-427 and Placebo to evaluate Pancreatic Cancer

Santa Monica : UCLA Medical Center

A Phase 1 clinical study for patients with Tumors, Pancreatic Cancer, Non-small Cell Lung Cancer or Esophagogastric Cancer

Colorado

Aurora : University of Colorado Hospital Anschutz Cancer Pavilion

A clinical trial to evaluate treatments using OMP-54F28, Nab-Paclitaxel and Gemcitabine for patients with Pancreatic Cancer or Stage IV Pancreatic Cancer

Aurora : Anschutz Cancer Pavillion

Patients are needed to participate in a clinical research study of Vantictumab, Nab-Paclitaxel and Gemcitabine to evaluate Pancreatic Cancer or Stage IV Pancreatic Cancer

Connecticut

Stamford : Stamford Hospital

Patients are needed to participate in a clinical research study of FOLFIRINOX, HyperAcute®-Pancreas Immunotherapy, 5-FU Chemoradiation and Gemcitabine to evaluate Pancreatic Cancer, Pancreatic Carcinoma Non-resectable or Locally Advanced Malignant Neoplasm

Florida

Boca Raton : Boca Raton Regional Hospital

Patients are needed to participate in a clinical research study of FOLFIRINOX, HyperAcute®-Pancreas Immunotherapy, 5-FU Chemoradiation and Gemcitabine to evaluate Pancreatic Cancer, Pancreatic Carcinoma Non-resectable or Locally Advanced Malignant Neoplasm

Fort Myers : Florida Cancer Specialists-South Updated

Patients are needed to participate in a clinical research study of OGX-427 and Placebo to evaluate Pancreatic Cancer

Gainesville : University of Florida

Patients are needed to participate in a clinical research study of FOLFIRINOX, HyperAcute®-Pancreas Immunotherapy, 5-FU Chemoradiation and Gemcitabine to evaluate Pancreatic Cancer, Pancreatic Carcinoma Non-resectable or Locally Advanced Malignant Neoplasm

Miami : University of Miami

Patients are needed to participate in a clinical research study of FOLFIRINOX, HyperAcute®-Pancreas Immunotherapy, 5-FU Chemoradiation and Gemcitabine to evaluate Pancreatic Cancer, Pancreatic Carcinoma Non-resectable or Locally Advanced Malignant Neoplasm

Orlando : MD Anderson Cancer Center Orlando

Patients are needed to participate in a clinical research study evaluating DCVax-Direct

Orlando : Florida Hospital Cancer Insitute Updated

Patients are needed to participate in a clinical research study of OGX-427 and Placebo to evaluate Pancreatic Cancer

Sarasota : Florida Cancer Specialists

A Phase 1 clinical study for patients with Tumors, Pancreatic Cancer, Non-small Cell Lung Cancer or Esophagogastric Cancer

St. Petersburg : Florida Cancer Specialists-North Updated

Patients are needed to participate in a clinical research study of OGX-427 and Placebo to evaluate Pancreatic Cancer

Tampa : USF Tampa General

Patients are needed to participate in a clinical research study of FOLFIRINOX, HyperAcute®-Pancreas Immunotherapy, 5-FU Chemoradiation and Gemcitabine to evaluate Pancreatic Cancer, Pancreatic Carcinoma Non-resectable or Locally Advanced Malignant Neoplasm

Tampa : H. Lee Moffitt Cancer Center

Patients are needed to participate in a clinical research study of FOLFIRINOX, HyperAcute®-Pancreas Immunotherapy, 5-FU Chemoradiation and Gemcitabine to evaluate Pancreatic Cancer, Pancreatic Carcinoma Non-resectable or Locally Advanced Malignant Neoplasm

Weston : Cleveland Clinic Florida

Patients are needed to participate in a clinical research study to evaluate Metastatic Pancreatic Cancer

Georgia

Savannah : Memorial University Medical Center

RTOG 0848: A Phase III Trial Evaluating Both Erlotinib and Chemoradiation as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma.

Augusta : Georgia Regents University

Patients are needed to participate in a clinical research study of NLG919 to evaluate Solid Tumors, Breast Cancer, Lung Cancer or Pancreatic Cancer

Illinois

Harvey : Ingalls Cancer Research Center Updated

Patients are needed to participate in a clinical research study of OGX-427 and Placebo to evaluate Pancreatic Cancer

Maywood : Loyola University Medical Center/Cardinal Bernardin Cancer Center

Patients are needed to participate in a clinical research study to evaluate Metastatic Pancreatic Cancer

Indiana

Goshen : Indiana University Health Goshen Center for Cancer Care

A clinical research study of IMMU-107, placebo and Gemcitabine for the treatment of Metastatic Pancreatic Cancer or Pancreatic Cancer

Goshen : Indiana University Health Goshen Center for Cancer Care

A Phase 1 clinical study for patients with Tumors, Pancreatic Cancer, Non-small Cell Lung Cancer or Esophagogastric Cancer

Goshen : Indiana University Health Goshen Center for Cancer Care

Patients are needed to participate in a clinical research study of FOLFIRINOX, HyperAcute®-Pancreas Immunotherapy, 5-FU Chemoradiation and Gemcitabine to evaluate Pancreatic Cancer, Pancreatic Carcinoma Non-resectable or Locally Advanced Malignant Neoplasm

Goshen : Indiana University Health, Goshen Center for Cancer Care

Patients are needed to participate in a clinical research study to evaluate Metastatic Pancreatic Cancer

Indianapolis : IU Health University Hospital

A clinical trial to evaluate treatments using OMP-54F28, Nab-Paclitaxel and Gemcitabine for patients with Pancreatic Cancer or Stage IV Pancreatic Cancer

Indianapolis : Indiana University

Patients are needed to participate in a clinical research study of FOLFIRINOX, HyperAcute®-Pancreas Immunotherapy, 5-FU Chemoradiation and Gemcitabine to evaluate Pancreatic Cancer, Pancreatic Carcinoma Non-resectable or Locally Advanced Malignant Neoplasm

Indianapolis : Indiana University Health Hospital

Patients are needed to participate in a clinical research study of Vantictumab, Nab-Paclitaxel and Gemcitabine to evaluate Pancreatic Cancer or Stage IV Pancreatic Cancer

Iowa

Iowa City : Holden Comprehensive Cancer Center

A Phase 1 clinical study for patients with Pancreatic Neoplasms

Louisiana

Shreveport : Fesit-Weiller Cancer Center

Patients are needed to participate in a clinical research study to evaluate Metastatic Pancreatic Cancer

Maryland

Baltimore : Johns Hopkins Kimmel Comprehensive Cancer Center

A clinical trial seeking patients for a research study for the treatment of Metastatic Pancreatic Cancer or Metastatic Colorectal Cancer

Baltimore : Johns Hopkins Hospital

A Phase 3 clinical study for patients with Pancreatic Solid Lesions or Pancreatic Mass

Bethesda : National Cancer Institute

A clinical trial seeking patients for a research study for the treatment of Metastatic, Locally Advanced Unresectable or Recurrent Pancreatic Cancer.

Bethesda : NCI, CCR

Patients are needed to participate in a clinical research study of GI-6301 to evaluate Solid Tumors

Massachusetts

Boston : Massachusetts General Hospital Dept. of Mass General Hospital

A clinical trial seeking patients for a research study for the treatment of Pancreatic Cancer

Boston : Dana Farber Cancer Institute

A clinical trial to evaluate treatments using TH-302, Nab-paclitaxel and Gemcitabine for patients with Pancreatic Cancer

Boston : Massachusetts General Hospital

A clinical trial to evaluate treatments using TH-302, Nab-paclitaxel and Gemcitabine for patients with Pancreatic Cancer

Michigan

Detroit : Karmanos Cancer Institute

Patients are needed to participate in a clinical research study of Cryoablation using Galil Medical systems and needles to evaluate Pain or Pancreatic Cancer

Detroit : Henry Ford Hospital

Patients are needed to participate in a clinical research study of FOLFIRINOX, HyperAcute®-Pancreas Immunotherapy, 5-FU Chemoradiation and Gemcitabine to evaluate Pancreatic Cancer, Pancreatic Carcinoma Non-resectable or Locally Advanced Malignant Neoplasm

Grand Rapids : Saint Mary's Health Care

Patients are needed to participate in a clinical research study to evaluate Metastatic Pancreatic Cancer

Minnesota

Minneapolis : Virginia Piper Cancer Institute

Patients are needed to participate in a clinical research study of FOLFIRINOX, HyperAcute®-Pancreas Immunotherapy, 5-FU Chemoradiation and Gemcitabine to evaluate Pancreatic Cancer, Pancreatic Carcinoma Non-resectable or Locally Advanced Malignant Neoplasm

Missouri

St. Louis : Washington University

A clinical trial to evaluate treatments using TH-302, Nab-paclitaxel and Gemcitabine for patients with Pancreatic Cancer

New Jersey

Hackensack : Hackensack University Medical Center

A clinical trial seeking patients for a research study for the treatment of Pancreatic Cancer

New Brunswick : Cancer Institute of New Jersey

Patients are needed to participate in a clinical research study of LDE-225 to evaluate Resectable Pancreatic Cancer

New York

Bronx : Montefiore Medical Center

A clinical trial seeking patients for a research study for the treatment of Metastatic, Locally Advanced Unresectable or Recurrent Pancreatic Cancer.

Lake Success : Arena Oncology Associates

A clinical trial to evaluate treatments for patients with Pancreatic Cancer

New York : Memorial Sloan Kettering Cancer Center MSKCC - SC

A clinical trial seeking patients for a research study for the treatment of Pancreatic Cancer

New York : Cornell University

A Phase 1 clinical study for patients with Tumors, Pancreatic Cancer, Non-small Cell Lung Cancer or Esophagogastric Cancer

New York : Mount Sinai Medical Center

Patients are needed to participate in a clinical research study of FOLFIRINOX, HyperAcute®-Pancreas Immunotherapy, 5-FU Chemoradiation and Gemcitabine to evaluate Pancreatic Cancer, Pancreatic Carcinoma Non-resectable or Locally Advanced Malignant Neoplasm

North Carolina

Durham : Duke University Medical Center

A clinical trial seeking patients for a research study for the treatment of Metastatic Pancreatic Cancer or Metastatic Colorectal Cancer

Durham : Duke University

A clinical trial seeking patients for a research study for the treatment of Metastatic, Locally Advanced Unresectable or Recurrent Pancreatic Cancer.

Durham : Duke University Medical Center

Patients are needed to participate in a clinical research study evaluating Mesenchymal-marker based ferrofluid (c-MET) and Epithelial cell adhesion molecule (EpCAM) ferrofluid

Winston-Salem : Wake Forest Baptist Health

Patients are needed to participate in a clinical research study of FOLFIRINOX, HyperAcute®-Pancreas Immunotherapy, 5-FU Chemoradiation and Gemcitabine to evaluate Pancreatic Cancer, Pancreatic Carcinoma Non-resectable or Locally Advanced Malignant Neoplasm

Ohio

Akron : Summa Health System - Cooper Cancer Center

Patients are needed to participate in a clinical research study to evaluate Metastatic Pancreatic Cancer

Cincinnati : Oncology Hematology Care, Inc. Updated

Patients are needed to participate in a clinical research study of OGX-427 and Placebo to evaluate Pancreatic Cancer

Cleveland : University Hospitals

Patients are needed to participate in a clinical research study of Cryoablation using Galil Medical systems and needles to evaluate Pain or Pancreatic Cancer

Oklahoma

Oklahoma City : Stephenson Cancer Center

A clinical trial to evaluate treatments using Vidaza for patients with Pancreatic Cancer

Oklahoma City : University of Oklahoma

Patients are needed to participate in a clinical research study of FOLFIRINOX, HyperAcute®-Pancreas Immunotherapy, 5-FU Chemoradiation and Gemcitabine to evaluate Pancreatic Cancer, Pancreatic Carcinoma Non-resectable or Locally Advanced Malignant Neoplasm

Oregon

Portland : Portland Providence Medical Center Updated

A Phase 1 clinical study for patients with Locally Advanced Malignant Neoplasm

Portland : Oregon Health and Science University

Patients are needed to participate in a clinical research study of FOLFIRINOX, HyperAcute®-Pancreas Immunotherapy, 5-FU Chemoradiation and Gemcitabine to evaluate Pancreatic Cancer, Pancreatic Carcinoma Non-resectable or Locally Advanced Malignant Neoplasm

Pennsylvania

Philadelphia : Fox Chase Cancer Center

A clinical trial to evaluate treatments using OMP-54F28, Nab-Paclitaxel and Gemcitabine for patients with Pancreatic Cancer or Stage IV Pancreatic Cancer

Philadelphia : Thomas Jefferson University

Patients are needed to participate in a clinical research study of FOLFIRINOX, HyperAcute®-Pancreas Immunotherapy, 5-FU Chemoradiation and Gemcitabine to evaluate Pancreatic Cancer, Pancreatic Carcinoma Non-resectable or Locally Advanced Malignant Neoplasm

Philadelphia : Fox Chase Cancer Center

Patients are needed to participate in a clinical research study of Vantictumab, Nab-Paclitaxel and Gemcitabine to evaluate Pancreatic Cancer or Stage IV Pancreatic Cancer

Philadelphia : Fox Chase Cancer Center

Patients are needed to participate in a clinical research study to evaluate Metastatic Pancreatic Cancer

Philadelphia : Thomas Jefferson University [Kimmel Cancer Center]

Patients are needed to participate in a clinical research study to evaluate Metastatic Pancreatic Cancer

Pittsburgh : UPMC Cancer Center

Patients are needed to participate in a clinical research study to evaluate Metastatic Pancreatic Cancer

South Carolina

Charleston : Medical University of South Carolina Hollings Cancer Center

Patients are needed to participate in a clinical research study to evaluate Metastatic Pancreatic Cancer

Columbia : South Carolina Oncology Associates Updated

Patients are needed to participate in a clinical research study of OGX-427 and Placebo to evaluate Pancreatic Cancer

Tennessee

Chattanooga : Tennessee Oncology - Chattanooga Updated

Patients are needed to participate in a clinical research study of OGX-427 and Placebo to evaluate Pancreatic Cancer

Knoxville : University of Tennessee Medical Center

Patients are needed to participate in a clinical research study of FOLFIRINOX, HyperAcute®-Pancreas Immunotherapy, 5-FU Chemoradiation and Gemcitabine to evaluate Pancreatic Cancer, Pancreatic Carcinoma Non-resectable or Locally Advanced Malignant Neoplasm

Nashville : Tennessee Oncology

A clinical research study of MORAb-066

Nashville : Vanderbilt

A Phase 1 clinical study for patients with Tumors, Pancreatic Cancer, Non-small Cell Lung Cancer or Esophagogastric Cancer

Nashville : Sarah Cannon Research Institute

A Phase 1 clinical study for patients with Tumors, Pancreatic Cancer, Non-small Cell Lung Cancer or Esophagogastric Cancer

Nashville : Tennessee Oncology, PLLC Updated

Patients are needed to participate in a clinical research study of OGX-427 and Placebo to evaluate Pancreatic Cancer

Nashville : Henry-Joyce Cancer Clinic

Patients are needed to participate in a clinical research study of Vantictumab, Nab-Paclitaxel and Gemcitabine to evaluate Pancreatic Cancer or Stage IV Pancreatic Cancer

Texas

Dallas : UT Southwestern Medical Center

A clinical trial seeking patients for a research study for the treatment of Metastatic Pancreatic Cancer or Metastatic Colorectal Cancer

Dallas : UT Southwestern Medical Center

A clinical trial seeking patients for a research study for the treatment of Metastatic, Locally Advanced Unresectable or Recurrent Pancreatic Cancer.

Dallas : UT Southwestern

A Phase 1 clinical study for patients with Tumors, Pancreatic Cancer, Non-small Cell Lung Cancer or Esophagogastric Cancer

Dallas : University of Texas Southwestern Medical Center

Patients are needed to participate in a clinical research study of FOLFIRINOX, HyperAcute®-Pancreas Immunotherapy, 5-FU Chemoradiation and Gemcitabine to evaluate Pancreatic Cancer, Pancreatic Carcinoma Non-resectable or Locally Advanced Malignant Neoplasm

Fort Worth : The Center for Cancer and Blood Disorders Updated

Patients are needed to participate in a clinical research study of OGX-427 and Placebo to evaluate Pancreatic Cancer

Galveston : University of Texas Medical Branch

Patients are needed to participate in a clinical research study to evaluate Metastatic Pancreatic Cancer

Houston : UT MD Anderson Cancer Center

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

Houston : MD Anderson Cancer Center

Patients are needed to participate in a clinical research study evaluating DCVax-Direct

Houston : UT MD Anderson Cancer Center

Patients are needed to participate in a clinical research study evaluating Interview and Questionnaire

Houston : Baylor College of Medicine

Patients are needed to participate in a clinical research study of FOLFIRINOX, HyperAcute®-Pancreas Immunotherapy, 5-FU Chemoradiation and Gemcitabine to evaluate Pancreatic Cancer, Pancreatic Carcinoma Non-resectable or Locally Advanced Malignant Neoplasm

San Antonio : GSK Investigational Site

A clinical trial to evaluate treatments using GSK1120212 and GSK2141795 for patients with Cancer

San Antonio : Novartis Investigative Site

A Phase 2 clinical study for patients with Cachexia

Utah

Salt Lake City : University of Utah / Huntsman Cancer Institute Huntsman UT

A clinical trial seeking patients for a research study for the treatment of Pancreatic Cancer

Salt Lake City : University of Utah

A Phase 1 clinical study for patients with Tumors, Pancreatic Cancer, Non-small Cell Lung Cancer or Esophagogastric Cancer

Virginia

Fairfax : Fairfax-Northern Virginia Haematology-Oncology

A clinical trial to evaluate treatments for patients with Pancreatic Cancer

Richmond : Virginia Cancer Institute Updated

Patients are needed to participate in a clinical research study of OGX-427 and Placebo to evaluate Pancreatic Cancer

Washington

Seattle : Virginia Mason Medical Center

A clinical research study of IMMU-107, placebo and Gemcitabine for the treatment of Metastatic Pancreatic Cancer or Pancreatic Cancer

Seattle : University of Washington - Seattle Cancer Center Alliance

Patients are needed to participate in a clinical research study of FOLFIRINOX, HyperAcute®-Pancreas Immunotherapy, 5-FU Chemoradiation and Gemcitabine to evaluate Pancreatic Cancer, Pancreatic Carcinoma Non-resectable or Locally Advanced Malignant Neoplasm

Tacoma : Northwest Medical Specialties

A Phase 1 clinical study for patients with Tumors, Pancreatic Cancer, Non-small Cell Lung Cancer or Esophagogastric Cancer

West Virginia

Morgantown : West Virginia University - Clinical Trials Research Unit

S1115 - Randomized Phase II Clinical Trial of AZD6244 Hydrogen Sulfate (NSC-748727) and MK-2206 (NSC-749607) vs mFOLFOX in Patients with Metastatic Pancreatic Cancer after Prior Chemotherapy

Wisconsin

Green Bay : Vince Lombardi Cancer Center

Patients are needed to participate in a clinical research study of FOLFIRINOX, HyperAcute®-Pancreas Immunotherapy, 5-FU Chemoradiation and Gemcitabine to evaluate Pancreatic Cancer, Pancreatic Carcinoma Non-resectable or Locally Advanced Malignant Neoplasm

Madison : University of Wisconsin

Patients are needed to participate in a clinical research study of FOLFIRINOX, HyperAcute®-Pancreas Immunotherapy, 5-FU Chemoradiation and Gemcitabine to evaluate Pancreatic Cancer, Pancreatic Carcinoma Non-resectable or Locally Advanced Malignant Neoplasm

Australia

Box Hill : Box Hill Hospital

A Phase 1 clinical study for patients with Pancreatic Cancer

Camperdown : Royal Prince Alfred Hospital

A Phase 1 clinical study for patients with Pancreatic Cancer

Heidelberg : The Austin Hospital

A Phase 1 clinical study for patients with Pancreatic Cancer

South Brisbane : Mater Medical Center

A clinical trial to evaluate treatments for patients with Pancreatic Cancer

Belgium

Canada

Toronto : Princess Margaret Hospital

Patients are needed to participate in a clinical research study evaluating AUY922 for the treatment of Adenocarcinoma of the Pancreas or Metastatic Disease

China

Beijing : Beijing Shijitan Hospital,CMU

A clinical research study of Recombinant hGM-CSF Herpes Simplex Virus Injection for the treatment of Melanoma, Liver Cancer, Pancreatic Cancer or Lung Cancer

Beijing : Beijing Cancer Hospital

A clinical trial seeking patients for a research study for the treatment of Pancreatic Neoplasms

Beijing : Beijing Cancer Hospital

Patients are needed to participate in a clinical research study of SOX sequential S-1 to evaluate Biliary Tract Cancer, Periampullary Adenocarcinoma or Pancreatic Cancer

Guangzhou : Sun Yat Sen University Cancer Center

A clinical trial seeking patients for a research study for the treatment of Pancreatic Neoplasms

Hangzhou : Sir Run Run Shaw Hospital Zhejiang University

A clinical trial seeking patients for a research study for the treatment of Pancreatic Neoplasms

Shanghai : Fudan University Shanghai Cancer Center

A clinical research study of Recombinant hGM-CSF Herpes Simplex Virus Injection for the treatment of Melanoma, Liver Cancer, Pancreatic Cancer or Lung Cancer

Shanghai : Shanghai Changhai Hospital

A clinical trial seeking patients for a research study for the treatment of Pancreatic Cancer

Shanghai : Shanghai First People's Hospital

A clinical trial seeking patients for a research study for the treatment of Pancreatic Neoplasms

Tianjin : Tianjin Medical University Cancer Institute and Hospital

Patients are needed to participate in a clinical research study evaluating M2ES and M2ES 60mg for the treatment of Pancreatic Cancer

France

Lomme : Hôpital Saint-Philibert

A clinical research study of EUS-FNA and nCLE

Lyon : Hôpital Jean Mermoz

A clinical research study of EUS-FNA and nCLE

Marseille : Institut Paoli Calmettes

A clinical research study of EUS-FNA and nCLE

Germany

Heidelberg : Clinic of General Surgery

A clinical trial to evaluate treatments using VXM01 and Placebo for patients with Stage IV Pancreatic Cancer

Köln :

Patients are needed to participate in a clinical research study for the treatment of Pancreatic Cancer

Italy

Japan

Gifu : Gifu University

Patients are needed to participate in a clinical research study evaluating PTFE Covered ComVi [full covered] Biliary Stent for the treatment of Cancer of Bile Duct or Pancreatic Cancer

Onomichi : Onomichi General Hospital

Patients are needed to participate in a clinical research study evaluating PTFE Covered ComVi [full covered] Biliary Stent for the treatment of Cancer of Bile Duct or Pancreatic Cancer

Sapporo : Teine-Keijinkai Hospital

Patients are needed to participate in a clinical research study evaluating PTFE Covered ComVi [full covered] Biliary Stent for the treatment of Cancer of Bile Duct or Pancreatic Cancer

Tokyo : The University of Tokyo

Patients are needed to participate in a clinical research study evaluating PTFE Covered ComVi [full covered] Biliary Stent for the treatment of Cancer of Bile Duct or Pancreatic Cancer

Tokyo : Toho University

Patients are needed to participate in a clinical research study evaluating PTFE Covered ComVi [full covered] Biliary Stent for the treatment of Cancer of Bile Duct or Pancreatic Cancer

Tokyo : Tokyo Medical University

Patients are needed to participate in a clinical research study evaluating PTFE Covered ComVi [full covered] Biliary Stent for the treatment of Cancer of Bile Duct or Pancreatic Cancer

Tokyo : Research Site

Patients are needed to participate in a clinical research study of TH-302 monotherapy, TH-302 and Gemcitabine to evaluate Solid Tumor or Pancreatic Cancer

Ube : Yamaguchi University

Patients are needed to participate in a clinical research study evaluating PTFE Covered ComVi [full covered] Biliary Stent for the treatment of Cancer of Bile Duct or Pancreatic Cancer

Korea, Republic of

Bucheon : Soon Chun Hyang University School of Medicine

Patients are needed to participate in a clinical research study evaluating PTFE Covered ComVi [full covered] Biliary Stent for the treatment of Cancer of Bile Duct or Pancreatic Cancer

Cheonan : Soon Chun Hyang University School of Medicine

Patients are needed to participate in a clinical research study evaluating PTFE Covered ComVi [full covered] Biliary Stent for the treatment of Cancer of Bile Duct or Pancreatic Cancer

Daegu : Catholic University of Daegu School of Medicine

Patients are needed to participate in a clinical research study evaluating PTFE Covered ComVi [full covered] Biliary Stent for the treatment of Cancer of Bile Duct or Pancreatic Cancer

Goyang-si : NATIONAL CANCER CENTER 323, Ilsan-ro, Ilsandong‐gu,

A clinical research study of Norzyme for the treatment of Pancreatic Cancer

Incheon : Inha University School of Medicine

Patients are needed to participate in a clinical research study evaluating PTFE Covered ComVi [full covered] Biliary Stent for the treatment of Cancer of Bile Duct or Pancreatic Cancer

Seoul : Gangnam Severance Hospital

Patients are needed to participate in a clinical research study evaluating PTFE Covered ComVi [full covered] Biliary Stent for the treatment of Cancer of Bile Duct or Pancreatic Cancer

Seoul : Seoul National University Hospital

Postoperative Oral Nutritional Supplementation After Major Gastrointestinal Surgery

Suwon : Ajou University School of Medicine

Patients are needed to participate in a clinical research study evaluating PTFE Covered ComVi [full covered] Biliary Stent for the treatment of Cancer of Bile Duct or Pancreatic Cancer

Netherlands

Groningen : University Medical Center Groningen

A clinical trial to evaluate treatments using 89Zr-MMOT0530A for patients

New Zealand

Christchurch : Christchurch Hospital

A Phase 1 clinical study for patients with Pancreatic Cancer

Hamilton : Waikato Hospital

A Phase 1 clinical study for patients with Pancreatic Cancer

Romania

Bucharest : Novartis Investigative Site

A Phase 2 clinical study for patients with Cachexia

Singapore

Outram Road : Singapore General Hospital

Patients are needed to participate in a clinical research study of 32P BioSilicon to evaluate Pancreatic Cancer

Spain

Madrid : Hospital Universitario 12 de Octubre

A clinical trial to evaluate treatments for patients with Pancreatic Cancer

Madrid : START Madrid

A Phase 1 clinical study for patients with Pancreatic Cancer

Sweden

Stockholm : Dept. of Oncology-Pathology, Karolinska University Hospital, Solna Updated

A clinical trial to evaluate treatments using AXP107-11 for patients with Adenocarcinoma

Stockholm : Dept. of Clinical Science, Intervention and Technology, Div. of surgery, Karolinska University Hospital, Huddinge Updated

A clinical trial to evaluate treatments using AXP107-11 for patients with Adenocarcinoma

Taiwan

Tainan : National Cheng Kung University Hospital

Patients are needed to participate in a clinical research study evaluating NC-6004 and Gemcitabine for the treatment of Locally Advanced Pancreatic Cancer or Metastatic Pancreatic Cancer

Taipei : Mackay Memorial Hospital

Patients are needed to participate in a clinical research study evaluating NC-6004 and Gemcitabine for the treatment of Locally Advanced Pancreatic Cancer or Metastatic Pancreatic Cancer

Taipei : Taipei Medical University Hospital

Patients are needed to participate in a clinical research study evaluating NC-6004 and Gemcitabine for the treatment of Locally Advanced Pancreatic Cancer or Metastatic Pancreatic Cancer

Taipei : Taipei Veterans General Hospital

Patients are needed to participate in a clinical research study evaluating NC-6004 and Gemcitabine for the treatment of Locally Advanced Pancreatic Cancer or Metastatic Pancreatic Cancer

Taipei : National Taiwan University Hospital

Patients are needed to participate in a clinical research study evaluating NC-6004 and Gemcitabine for the treatment of Locally Advanced Pancreatic Cancer or Metastatic Pancreatic Cancer

United Kingdom

Bournemouth : The Royal Bournemouth Hospital

A clinical research study of Placebo and Caprelsa (vandetanib) for the treatment of Pancreatic Cancer

Cambridge : Cambridge University Hospitals NHS Foundation Trust

A clinical trial to evaluate treatments using Pazopanib for patients

Guildford : Royal Surrey County Hospital

A clinical research study of Placebo and Caprelsa (vandetanib) for the treatment of Pancreatic Cancer

Liverpool : Clatterbridge Centre for Oncology

A clinical research study of Placebo and Caprelsa (vandetanib) for the treatment of Pancreatic Cancer

Liverpool : Royal Liverpool University Hospital

A clinical research study of Placebo and Caprelsa (vandetanib) for the treatment of Pancreatic Cancer

Liverpool : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Pancreatic Cancer

London : Guys & St Thomas Hospital

A clinical research study of Placebo and Caprelsa (vandetanib) for the treatment of Pancreatic Cancer

London : Guy's and St Thomas' Hospital NHS Trust

Patients are needed to participate in a clinical research study of 32P BioSilicon to evaluate Pancreatic Cancer

Manchester : The Christie Hospital

A clinical research study of Placebo and Caprelsa (vandetanib) for the treatment of Pancreatic Cancer

Middlesbrough : James Cook University Hospital

A clinical research study of Placebo and Caprelsa (vandetanib) for the treatment of Pancreatic Cancer

Nottingham : Nottingham City Hospital

A clinical research study of Placebo and Caprelsa (vandetanib) for the treatment of Pancreatic Cancer

Sheffield : Weston Park Hospital

A clinical research study of Placebo and Caprelsa (vandetanib) for the treatment of Pancreatic Cancer

Sutton : The Royal Marsden NHS Trust

Patients are needed to participate in a clinical research study evaluating UFT, Leucovorin and UFT/ Leucovorin + Cetuximab + Radiotherapy for the treatment of Pancreatic Cancer

>